Encompass Health (EHC) Competitors

$85.45
+0.01 (+0.01%)
(As of 05/17/2024 ET)

EHC vs. SEM, CHE, GMED, ELAN, BIO, ROIV, HSIC, PEN, LEGN, and VKTX

Should you be buying Encompass Health stock or one of its competitors? The main competitors of Encompass Health include Select Medical (SEM), Chemed (CHE), Globus Medical (GMED), Elanco Animal Health (ELAN), Bio-Rad Laboratories (BIO), Roivant Sciences (ROIV), Henry Schein (HSIC), Penumbra (PEN), Legend Biotech (LEGN), and Viking Therapeutics (VKTX). These companies are all part of the "medical" sector.

Encompass Health vs.

Encompass Health (NYSE:EHC) and Select Medical (NYSE:SEM) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, community ranking, risk, dividends, earnings and valuation.

Encompass Health has higher earnings, but lower revenue than Select Medical. Select Medical is trading at a lower price-to-earnings ratio than Encompass Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Encompass Health$4.80B1.79$352M$3.7023.10
Select Medical$6.66B0.66$243.49M$2.1016.17

Encompass Health received 159 more outperform votes than Select Medical when rated by MarketBeat users. Likewise, 71.83% of users gave Encompass Health an outperform vote while only 57.85% of users gave Select Medical an outperform vote.

CompanyUnderperformOutperform
Encompass HealthOutperform Votes
487
71.83%
Underperform Votes
191
28.17%
Select MedicalOutperform Votes
328
57.85%
Underperform Votes
239
42.15%

97.3% of Encompass Health shares are held by institutional investors. Comparatively, 89.5% of Select Medical shares are held by institutional investors. 2.1% of Encompass Health shares are held by company insiders. Comparatively, 19.1% of Select Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Encompass Health has a beta of 0.92, suggesting that its stock price is 8% less volatile than the S&P 500. Comparatively, Select Medical has a beta of 1.38, suggesting that its stock price is 38% more volatile than the S&P 500.

In the previous week, Encompass Health had 4 more articles in the media than Select Medical. MarketBeat recorded 11 mentions for Encompass Health and 7 mentions for Select Medical. Select Medical's average media sentiment score of 0.76 beat Encompass Health's score of 0.75 indicating that Select Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Encompass Health
6 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Select Medical
4 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Encompass Health has a net margin of 7.60% compared to Select Medical's net margin of 3.97%. Select Medical's return on equity of 18.11% beat Encompass Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Encompass Health7.60% 18.01% 6.55%
Select Medical 3.97%18.11%3.64%

Encompass Health currently has a consensus target price of $90.29, indicating a potential upside of 5.63%. Select Medical has a consensus target price of $34.25, indicating a potential upside of 0.88%. Given Encompass Health's stronger consensus rating and higher probable upside, research analysts clearly believe Encompass Health is more favorable than Select Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Encompass Health
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
3.13
Select Medical
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50

Encompass Health pays an annual dividend of $0.60 per share and has a dividend yield of 0.7%. Select Medical pays an annual dividend of $0.50 per share and has a dividend yield of 1.5%. Encompass Health pays out 16.2% of its earnings in the form of a dividend. Select Medical pays out 23.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Summary

Encompass Health beats Select Medical on 15 of the 21 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EHC vs. The Competition

MetricEncompass HealthHospitals IndustryMedical SectorNYSE Exchange
Market Cap$8.60B$4.57B$5.15B$18.06B
Dividend Yield0.70%1.08%43.85%3.44%
P/E Ratio23.1013.09120.5322.17
Price / Sales1.790.932,354.7710.69
Price / Cash13.129.1836.5620.09
Price / Book3.642.375.726.01
Net Income$352M$178.36M$105.31M$966.25M
7 Day Performance-1.23%-1.98%1.85%1.87%
1 Month Performance8.69%8.32%4.74%7.16%
1 Year Performance38.91%4.87%7.74%21.68%

Encompass Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SEM
Select Medical
4.8597 of 5 stars
$34.08
+1.1%
$34.25
+0.5%
+21.0%$4.43B$6.66B16.2354,600Analyst Revision
CHE
Chemed
4.982 of 5 stars
$568.76
0.0%
$681.00
+19.7%
+4.6%$8.61B$2.26B30.6115,087Insider Selling
Positive News
GMED
Globus Medical
4.5161 of 5 stars
$62.87
-1.4%
$66.50
+5.8%
+13.4%$8.51B$1.57B98.245,000Insider Selling
Short Interest ↑
ELAN
Elanco Animal Health
3.0007 of 5 stars
$17.07
+0.4%
$18.29
+7.1%
+98.8%$8.44B$4.42B-6.449,300Short Interest ↓
Positive News
BIO
Bio-Rad Laboratories
4.6426 of 5 stars
$294.05
+3.0%
$461.00
+56.8%
-22.8%$8.39B$2.67B-28.388,030Short Interest ↑
ROIV
Roivant Sciences
2.436 of 5 stars
$11.33
+1.3%
$16.90
+49.2%
+24.2%$9.13B$61.28M2.18904News Coverage
Positive News
HSIC
Henry Schein
4.0176 of 5 stars
$72.77
-0.5%
$81.73
+12.3%
-2.5%$9.35B$12.34B24.5825,000
PEN
Penumbra
4.8051 of 5 stars
$208.73
+1.9%
$300.64
+44.0%
-35.1%$8.09B$1.06B88.074,200Insider Selling
LEGN
Legend Biotech
2.3532 of 5 stars
$44.38
+3.3%
$82.64
+86.2%
-36.7%$8.07B$285.14M-29.991,800Earnings Report
Analyst Forecast
Analyst Revision
VKTX
Viking Therapeutics
4.4999 of 5 stars
$72.50
+0.2%
$112.25
+54.8%
+174.5%$7.99BN/A-77.9628Analyst Forecast
News Coverage

Related Companies and Tools

This page (NYSE:EHC) was last updated on 5/18/2024 by MarketBeat.com Staff

From Our Partners